Blood Journal Article – A Study Update for 10MM01: Carfilzomib and Pomalidomide with Dexamethasone in Multiple Myeloma

This is the first clinical trial to investigate CPD in multiple myeloma. Results suggest that the regimen is a well-tolerated and highly active combination for patients with relapsed/refractory multiple myeloma.

View the journal article (PDF).

Recommended Posts